Cargando…
Time from symptom onset to severe COVID-19 and risk factors among patients in Southern Ethiopia: a survival analysis
OBJECTIVE: This study aimed to assess the time to severe coronavirus disease 2019 (COVID-19) and risk factors among confirmed COVID-19 cases in Southern Ethiopia. METHOD: This two-center retrospective cohort study involved patients with confirmed COVID-19 from 1 October 2020 to 30 September 2021. Ka...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9425909/ https://www.ncbi.nlm.nih.gov/pubmed/36036178 http://dx.doi.org/10.1177/03000605221119366 |
_version_ | 1784778563090644992 |
---|---|
author | Sisay, Gizaw Mantefardo, Bahru Beyene, Aster |
author_facet | Sisay, Gizaw Mantefardo, Bahru Beyene, Aster |
author_sort | Sisay, Gizaw |
collection | PubMed |
description | OBJECTIVE: This study aimed to assess the time to severe coronavirus disease 2019 (COVID-19) and risk factors among confirmed COVID-19 cases in Southern Ethiopia. METHOD: This two-center retrospective cohort study involved patients with confirmed COVID-19 from 1 October 2020 to 30 September 2021. Kaplan–Meier graphs and log-rank tests were used to determine the pattern of COVID-19 severity among categories of variables. Bivariable and multivariable Cox proportional regression models were used to identify the risk factors of severe COVID-19. RESULTS: Four hundred thirteen patients with COVID-19 with a mean age of 41.9 ± 15.3 years were involved in the study. There were 194 severe cases (46.9.1%), including 77 (39.6%) deaths. The median time from symptom onset to severe COVID-19 was 8 days (interquartile range: 7–12 days). The risk factors for severe COVID-19 were age >65 (adjusted hazard ratio [AHR] = 2.65, 95% confidence interval [95%CI]: 1.02, 3.72), cough (AHR = 1.59, 95%CI: 1.39, 2.84), chest pain (AHR = 1.47, 95%CI: 1.34, 2.66), headache (AHR = 2.04, 95%CI: 1.43, 2.88), comorbidity (AHR = 1.3, 95%CI: 1.01, 2.04), asthma (AHR = 1.6. 95%CI: 1.04, 2.24), and symptom onset to admission more than 5 days (AHR = 0.48, 95%CI: 0.34, 0.68). CONCLUSION: Patients with symptoms and comorbidities should be closely monitored. |
format | Online Article Text |
id | pubmed-9425909 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-94259092022-08-31 Time from symptom onset to severe COVID-19 and risk factors among patients in Southern Ethiopia: a survival analysis Sisay, Gizaw Mantefardo, Bahru Beyene, Aster J Int Med Res Retrospective Clinical Research Report OBJECTIVE: This study aimed to assess the time to severe coronavirus disease 2019 (COVID-19) and risk factors among confirmed COVID-19 cases in Southern Ethiopia. METHOD: This two-center retrospective cohort study involved patients with confirmed COVID-19 from 1 October 2020 to 30 September 2021. Kaplan–Meier graphs and log-rank tests were used to determine the pattern of COVID-19 severity among categories of variables. Bivariable and multivariable Cox proportional regression models were used to identify the risk factors of severe COVID-19. RESULTS: Four hundred thirteen patients with COVID-19 with a mean age of 41.9 ± 15.3 years were involved in the study. There were 194 severe cases (46.9.1%), including 77 (39.6%) deaths. The median time from symptom onset to severe COVID-19 was 8 days (interquartile range: 7–12 days). The risk factors for severe COVID-19 were age >65 (adjusted hazard ratio [AHR] = 2.65, 95% confidence interval [95%CI]: 1.02, 3.72), cough (AHR = 1.59, 95%CI: 1.39, 2.84), chest pain (AHR = 1.47, 95%CI: 1.34, 2.66), headache (AHR = 2.04, 95%CI: 1.43, 2.88), comorbidity (AHR = 1.3, 95%CI: 1.01, 2.04), asthma (AHR = 1.6. 95%CI: 1.04, 2.24), and symptom onset to admission more than 5 days (AHR = 0.48, 95%CI: 0.34, 0.68). CONCLUSION: Patients with symptoms and comorbidities should be closely monitored. SAGE Publications 2022-08-28 /pmc/articles/PMC9425909/ /pubmed/36036178 http://dx.doi.org/10.1177/03000605221119366 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by-nc/4.0/Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Retrospective Clinical Research Report Sisay, Gizaw Mantefardo, Bahru Beyene, Aster Time from symptom onset to severe COVID-19 and risk factors among patients in Southern Ethiopia: a survival analysis |
title | Time from symptom onset to severe COVID-19 and risk factors among patients in Southern Ethiopia: a survival analysis |
title_full | Time from symptom onset to severe COVID-19 and risk factors among patients in Southern Ethiopia: a survival analysis |
title_fullStr | Time from symptom onset to severe COVID-19 and risk factors among patients in Southern Ethiopia: a survival analysis |
title_full_unstemmed | Time from symptom onset to severe COVID-19 and risk factors among patients in Southern Ethiopia: a survival analysis |
title_short | Time from symptom onset to severe COVID-19 and risk factors among patients in Southern Ethiopia: a survival analysis |
title_sort | time from symptom onset to severe covid-19 and risk factors among patients in southern ethiopia: a survival analysis |
topic | Retrospective Clinical Research Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9425909/ https://www.ncbi.nlm.nih.gov/pubmed/36036178 http://dx.doi.org/10.1177/03000605221119366 |
work_keys_str_mv | AT sisaygizaw timefromsymptomonsettoseverecovid19andriskfactorsamongpatientsinsouthernethiopiaasurvivalanalysis AT mantefardobahru timefromsymptomonsettoseverecovid19andriskfactorsamongpatientsinsouthernethiopiaasurvivalanalysis AT beyeneaster timefromsymptomonsettoseverecovid19andriskfactorsamongpatientsinsouthernethiopiaasurvivalanalysis |